The European Medicines Agency has issued a negative opinion to an application from Amsterdam Molecular Therapeutics BV for a gene therapy to treat patients with an enzyme deficiency that is linked with pancreatitis. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
